Moderna completes enrollment in its large COVID-19 vaccine study

London, October 22

Moderna Inc said on Thursday it had completed enrolling 30,000 participants in a late-stage study testing its experimental coronavirus vaccine.

Over 25,650 participants have so far received their second shot of the vaccine candidate, mRNA-1273, the company said.

Moderna said its study includes more than 11,000 participants from minority communities in the US, representing 37 per cent of the study population. Reuters

Join Whatsapp Channel of The Tribune for latest updates.